Skip to main content
ABVC
NASDAQ Life Sciences

ABVC Closes $3.39M Discounted Convertible Note Deal and Settles Lind Litigation for $625,000

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$1.05
Mkt Cap
$28.027M
52W Low
$0.707
52W High
$3.06
52W Position info
49% above low
Off High info
66% below high
Rel. Volume
Market data snapshot near publication time

ABVC sits 49% above its 52-week low of $0.707.

Summary

ABVC closed a $3.39 million private placement of 17.5% OID convertible notes with $4.1 million principal, converting at 85% of VWAP, and used part of the proceeds to pay $625,000 to settle the Lind lawsuit and cancel the Lind notes.


Key Events · Financing and Capital Events · ABVC

  • Discounted Convertible Note Placement Closes

    On October 30, 2026, the company sold $4,106,060 principal of 17.5% OID senior convertible notes for $3,387,500 gross. The notes mature June 30, 2027, with a one-time three-month extension that adds 5% to principal.

  • Conversion Terms Below Market

    Conversion is at 85% of the three-day VWAP with a $0.20 floor, but not before the eight-month anniversary and only with company consent before maturity; 20,530,304 shares are reserved initially.

  • Lind Lawsuit Settled for $625,000

    Under the October 26, 2026 settlement, Lind receives $625,000, the Lind notes are cancelled, all liens are released, the 398,000-share Lind Warrant is increased by 20%, and Lind gets a 12-month 10-25% participation right in future financings.

  • Net Cash Roughly $2.5 Million

    After the $237,125 placement agent fee (7%), $65,000 of expense reimbursement, and the $625,000 Lind payment, the remainder funds working capital and subsidiaries.


Analysis · ABVC · Life Sciences

The cost of capital here is steep: ABVC raised $3.39 million in cash against $4.1 million of principal — a 17.5% original issue discount — and the notes convert at 85% of a three-day VWAP, so conversion shares are priced below market by design. Roughly $625,000 of the proceeds goes straight out the door to Lind Global Fund II to end a lawsuit filed in February 2026 and clear the old notes and liens, leaving net cash for operations closer to $2.5 million after the $237,125 placement fee and $65,000 of expense reimbursement. With a Q2 10-Q that already flagged going-concern doubt and minimal cash, this buys time rather than solving the balance sheet. The 19.99% Nasdaq exchange cap means the company must win a shareholder vote by June 30, 2027 or the notes go into default, and the six-month ban on other variable-rate deals limits how it can raise money in the interim.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ABVC was trading at $1.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $28M. The 52-week trading range was $0.71 to $3.06. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ABVC - Latest Insights

ABVC
Nov 10, 2026, 6:20 PM EST
Filing Type: S-3/A
Importance Score:
7
Price at Filing: $1.00
Real-time Price: $0.940 info
Change: -$0.060 (-6%) info
Market Cap: $25.358M info
ABVC
Nov 10, 2026, 4:50 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.00
Real-time Price: $0.940 info
Change: -$0.060 (-6%) info
Market Cap: $25.358M info
ABVC
Nov 02, 2026, 9:30 AM EST
Source: EQS
Importance Score:
7
Price at Filing: $1.04
Real-time Price: $0.940 info
Change: -$0.100 (-10%) info
Market Cap: $25.358M info
ABVC
Sep 29, 2026, 12:22 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.03
Real-time Price: $0.940 info
Change: -$0.090 (-9%) info
Market Cap: $25.358M info
ABVC
Sep 11, 2026, 4:30 PM EDT
Filing Type: PRER14A
Importance Score:
7
Price at Filing: $1.01
Real-time Price: $0.940 info
Change: -$0.070 (-7%) info
Market Cap: $25.358M info